Patent · US Active

Anti-IL-6/IL-6R antibodies and methods of use thereof

US10759862B2 · kind B2 · utility

1Cited by

15References

6Claims

0Family size

Assignee

Novimmune SA · CH

Inventors

Walter Ferlin · Annemasse, FR
Marie Kosco-Vilbois · Saint-Julien-en-Genevois, FR
Greg Elson · Saint-Julien-en-Genevois, FR
Olivier Leger · Bonneville, FR
Florence Guilhot · Saint-Julien-en-Genevois, FR

Key dates

Filing date	Nov 27, 2017
Grant date	Sep 1, 2020
Priority date	—
Expiry date	Nov 27, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/92
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention provides fully human monoclonal antibodies that recognize the IL-6/IL-6R complex. The invention further provides methods of using such monoclonal antibodies as a therapeutic, diagnostic, and prophylactic.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.